Publication
Number of items: 30.
Article
  • Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders : A multicenter-observational study. (2017) Tiziano Acciavatti, Matteo Lupi, Rita Santacroce, Andrea Aguglia, Luigi Attademo, Laura Bandini, Paola Ciambrone, Giulia Lisi, Giovanni Migliarese, Federica Pinna, Diego Quattrone, Michele Ribolsi, Maria Salvina Signorelli, Salvatore Calò, Fabrizio Schifano, Massimo di Giannantonio and Giovanni Martinotti
  • Captagon: Use and Trade in the Middle East. (2017) Ahmed Al-Imam, Rita Santacroce, Andres Roman-Urrestarazu, Robert Chilcott, G. Martinotti, Giuseppe Bersani and Ornella Corazza
  • Injecting eye-drops : a mini-review on the non-clinical misuse of Tropicamide. (2015) Francesco Saverio Bersani, C. Imperatori, M. Prilutskaya, K. Kuliev and Ornella Corazza
  • Treatments used for obsessive-compulsive disorder-An international perspective. (2019) Vlasios Brakoulias, Vladan Starcevic, Umberto Albert, Shyam Sundar Arumugham, Brenda E Bailey, Amparo Belloch, Tania Borda, Liliana Dell'Osso, Jason A Elias, Martha J Falkenstein, Ygor A Ferrao, Leonardo F Fontenelle, Lena Jelinek, Leto Kalogeraki, Brian Kay, Luana D Laurito, Christine Lochner, Giuseppe Maina, Donatella Marazziti, Andrew Martin, Hisato Matsunaga, Euripedes C Miguel, Pedro Morgado, Irakis Mourikis, Massimo Pasquini, Rodrigo Perez Rivera, Sriramya Potluri, Janardhan Y C Reddy, Brian C Riemann, Maria Conceição do Rosario, Roseli G Shavitt, Dan J Stein, Kirupumani Viswasam, Zhen Wang and Naomi A Fineberg
  • Methoxetamine-related deaths in the UK : an overview. (2015) Stephania Chiappini, Hugh Claridge, John Corkery, Christine Goodair, Barbara Loi and Fabrizio Schifano
  • Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances (NPS) in the EU : the outcomes of the ReDNet project. (2013) Ornella Corazza, Sulaf Assi, Pierluigi Simonato, John Corkery, Saverio Bersani, Zsolt Demetrovics, Jacqueline Stair, Suzanne Fergus, Cinzia Pezzolesi, Manuela Pasinetti, Paolo Deluca, C. Drummond, Ursula Blaszko, Jacek Moskalewicz, Barbara Mervo, Lucia Di Furia, Magi Farre, Liv Flesland, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Elias Sferrazza, Marta Torrens, Farran Sambola, Peer van der Kreeft, Norbert Scherbaum and Fabrizio Schifano
  • Novel Psychoactive Substances: shedding new lights on the ever-changing drug scenario and the associated health risks. (2017) Ornella Corazza, Andy Parrott and Zsolt Demetrovics
  • Phenomenon of new drugs on the Internet : the case of ketamine derivative methoxetamine. (2012) Ornella Corazza, Fabrizio Schifano, Pierluigi Simonato, Suzanne Fergus, Sulaf Assi, Jacqueline Stair, John Corkery, Giuseppina Trincas, Paolo Deluca, Zoe Davey, Ursula Blaszko, Zsolt Demetrovics, Jacek Moskalewicz, Aurora Enea, Giuditta di Melchiorre, Barbara Mervo, Lucia Di Furia, Magi Farre, Liv Flesland, Manuela Pasinetti, Cinzia Pezzolesi, Agnieszka Pisarska, Harry Shapiro, Holger Siemann, Arvid Skutle, Aurora Enea, Giuditta di Melchiorre, Elias Sferrazza, Marta Torrens, Peer van der Kreeft, Daniela Zummo and Norbert Scherbaum
  • The use of ketamine as an antidepressant: : A systematic review and meta-analysis. (2015) Caoimhe M. Coyle and K.R. Laws
  • An international survey on the awareness, use, preference and health perception of Novel Psychoactive Substances (NPS). (2017) Elena Deligianni, John Corkery, Fabrizio Schifano and Lisa Lione
  • Venlafaxine as the ‘baby ecstasy’? : Literature overview and analysis of web-based misusers’ experiences. (2015) Giulia Francesconi, Laura Orsolini, John Corkery, Duccio Papanti and Fabrizio Schifano
  • Intended and Unintended Use of Cathinone Mixtures. (2017) Amira Guirguis, John Corkery, Jacqueline Stair, Stewart Kirton, Mire Zloh and Fabrizio Schifano
  • Obstacles to Treatment retention in Opioid Use Disorder: An International Substance Use Disorder Treatment Worker Survey. (2023) Matthew Jones, Amira Guirguis, Alan Watkins, Ceri Bradshaw, Lily Mohamed and Fabrizio Schifano
  • Enhancing sexual desire and experience : an investigation on the sexual correlates of gamma-hydroxybutyrate (GHB) use. (2015) M. Kapitány-Fövény, B. Mervo, Ornella Corazza, K. Kökönyei, J. Farkas, R. Urbán, G. Zacher and Zsolt Demetrovics
  • Deaths of individuals aged 16-24 years in the UK after using mephedrone. (2015) Barbara Loi, John Corkery, Hugh Claridge, Christine Goodair, Stephania Chiappini, Carla Gimeno Clemente and Fabrizio Schifano
  • 4,4’-dimethylaminorex (‘4,4’-DMAR’; ‘Serotoni’) misuse; a web-based study. (2017) Barbara Loi, Mire Zloh, Maria Antonietta, John Corkery and Fabrizio Schifano
  • Hair analysis for the detection of drug use – is there potential for evasion? (2017) Shanna Marrinan, Andres Roman-Urrestarazu, Declan Naughton, Emerlinda Levari, John Collins, Robert Chilcott, Giuseppe Bersani and Ornella Corazza
  • The use of supplements and performance and image enhancing drugs in fitness settings: a cross‐sectional investigation in the United Kingdom. (2017) Roisin Mooney, Pierluigi Simonato, Risha Ruparelia, Andres Roman-Urrestarazu, Giovanni Martinotti and Ornella Corazza
  • Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone? (2015) Kapitány-Fövény Máté, Barbara Mervo, Máté Kertész, Ornella Corazza, J. Farkas, G. Kökönyei, R. Urbán and Zsolt Demetrovics
  • From concept(ion) to life after death/the grave: the ‘natural’ history and life-cycle(s) of Novel Psychoactive Substances (NPS). (2017) Laura Orsolini, John Corkery, Duccio Papanti and Fabrizio Schifano
  • Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces. (2015) Laura Orsolini, Giulia Francesconi, Duccio Papanti, Arianna Giorgetti and Fabrizio Schifano
  • An insight into the deep web; why it matters for addiction psychiatry? (2017) Laura Orsolini, Duccio Papanti, John Corkery and Fabrizio Schifano
  • A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans. (2022) Elisabeth Prevete, Kim Paula Colette Kuypers, Eef Lien Theunissen, Ornella Corazza, Giuseppe Bersani and Johannes Gerardus Ramaekers
  • A matter of life and death : substance-caused and substance-related fatalities in Ibiza in 2015. (2017) Rita Santacroce, Claudia Ruiz Bennasar, Juan Ramon Sancho Jaraiz, Federica Fiori, Fabiola Sarchione, Federica Angelini, Gabriella Catalano, Maria Luisa Carenti, John Martin Corkery, Fabrizio Schifano, Massimo di Giannantonio and Giovanni Martinotti
  • Is there a potential of misuse for Magnolia officinalis compounds/metabolites? (2017) Fabrizio Schifano, Valentina Guarino, Duccio G. Papanti, Jacopo Baccarin, Laura Orsolini and John M. Corkery
  • Exploring the understanding, source of availability and level of access of cognitive enhancers among university students in the United Arab Emirates: a qualitative study. (2023) Safia Sharif, Suzanne Fergus, Amira Guirguis, Nigel Smeeton and Fabrizio Schifano
  • Can mobile phone technology support a rapid sharing of information on Novel Psychoactive Substances among health and other professionals internationally? (2017) Pierluigi Simonato, Francesco Saverio Bersani, Rita Santacroce, Eduardo Cinosi, Fabrizio Schifano, Giuseppe Bersani, Giovanni Martinotti and Ornella Corazza
  • Changing Trends in the Use of Kratom (Mitragyna speciosa) in Southeast Asia. (2017) D Singh, S Narayanan, B Vicknasingam, Ornella Corazza, Rita Santacroce and Andres Roman-Urrestarazu
  • Olanzapine as the ideal ‘trip terminator’? : Analysis of online reports relating to antipsychotics’s use and misuse following occurance of novel psychoactive substance-related psychotic symptoms. (2015) Giuseppe Valeriani, Ornella Corazza, Francesco Saverio Bersani, Claudia Melcore, Antonio Metastasio, Giuseppe Bersani and Fabrizio Schifano
  • Detecting a signal in the noise : Monitoring the global spread of novel psychoactive substances using media and other open source information. (2015) Matthew Young, C. Dubeau and Ornella Corazza